Information Library
Results for: Consulting - North and Central America - United States
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Quintiles Backs Change to Marketing Mix as NHS Reforms Take Hold
Press Release — READING, UK – 30 May, 2012 – Quintiles has released the first in a series of briefing papers looking at how market access strategies can
-
UK Market Access Insight Brief
Podcast — May 30, 2012
Insight Briefing series on Market Access in key European countries -
FDA News Annual Risk Management and Drug Safety Summit
Event — Conference Date(s): November 1 - November 2, 2012
Location: Washington, DC
-
ISPOR US 2012
Event — Conference Date(s): June 2 - June 6, 2012
Location: Washington, DC
-
DIA US 2012
Event — Conference Date(s): June 24 - June 28, 2012
Location: Philadelphia, PA Pennsylvania Convention Center
Booth Number: 1401
-
Quintiles and Population Genetics Technologies Partner
Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.
-
Dr. Frank Massam
Hear from the Experts — May 13, 2011
Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd. -
Vaccine Insights
Presentation — April 19, 2011
Quintiles’ Jason Baumgartner, Life Sciences Consulting Director, presented on “Understanding Socio-Economic Drivers to Increase Vaccination Coverage” at the World Vaccine Congress 2011 -
New Healthcare Architecture to Maximize Vaccine Coverage Rates
Hear from the Experts — April 19, 2011
Jason Baumgartner discusses the steps required to create a complete healthcare architecture the shift among biopharma toward preventive medicine. -
The Patient is Waiting - Quality's Quiet Impact on the Public Trust - Risky Business, Chapter 8
Hear from the Experts — February 2, 2011
Chapter Excerpt from Risky Business: Managing the Quality of America’s Medicines Chapter eight carefully steps into the controversies surrounding the public’s expectations about the affordability, effectiveness and safety of prescription drugs.
